AMGN241101P302500
- 2.55
- -1.05-29.17%
Amgen Newsroom
Market Climbs as Investors Prepare for Biggest Earnings Week of the Year | Live Stock
RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $362
Apple, Microsoft, Exxon, and More Stocks to Watch
Weekly Buzz: Is Tesla a sign of earnings to come?
Friday Market Falls With Busy Business Ahead | Wall Street Today
Amgen Declares $2.25 Dividend
Express News | Amgen Announces 2024 Fourth Quarter Dividend
Amgen Likely to See Q3 Miss, Long-Term Positive Revenue Growth, Oppenheimer Says
Amgen Inc. (NASDAQ:AMGN) Shares Could Be 39% Below Their Intrinsic Value Estimate
Mooer's Stories | How Stock_Drift Navigates Irrational Markets
Friday Market Climbs After Big Earnings, and More to Come | Live Moovin' Stocks
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Earnings Preview: Amgen to Report Financial Results Post-market on October 30
AMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTS
A Closer Look at Amgen's Options Market Dynamics
Amgen Gears Up to Report Q3 Earnings: Here's What to Expect
Dow's Nearly 300-Point Drop Led By Losses For Shares Of McDonald'S, Boeing
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $335
Bernstein Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380